2,4-Dihydroxybenzoic acid
Common Name: |
2,4-Dihydroxybenzoic acid |
IUPAC Name: |
2,4-dihydroxybenzoic acid |
Molecular Formula: |
C7H6O4 |
SMILES: |
C1=CC(=C(C=C1O)O)C(=O)O |
Inchi: |
1S/C7H6O4/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,8-9H,(H,10,11) |
Inchi Key: |
UIAFKZKHHVMJGS-UHFFFAOYSA-N |
Cas No: |
89-86-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
154.12 |
Mass (g/mol) |
154.027 |
Molar Refractivity |
37.45 |
Net Charge |
-1 |
HBD |
3 |
HBA |
4 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
77.76 |
Hetero Atoms |
4 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
225.00 to 227.00 |
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.00 |
LogP |
0.796 |
iLOGP |
0.75 |
XLOGP3 |
1.63 |
WLOGP |
0.80 |
MLOGP |
0.40 |
ESOL Log S |
-2.16 |
ESOL Solubility (mg/ml) |
1.07 |
ESOL Solubility (mol/l) |
0.007 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.88 |
Ali Solubility (mg/ml) |
0.21 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-0.60 |
Silicos-IT Solubility (mg/ml) |
38.3 |
Silicos-IT Solubility (mol/l) |
0.25 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.08 |
Bioavailability Score |
0.56 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.734 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
1 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.076 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |